For decades, assessing cholesterol risk has been built around a simple idea: Lower “bad” cholesterol, lower your chance of a heart attack. The test at the center of that approach measures how much low-density lipoprotein, or LDL cholesterol, is circulating in part of the blood. It has shaped everything from clinical guidelines to the widespread